These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 15675890)

  • 1. Use of etanercept in the dermatology setting. A review.
    Lebwohl MG
    Am J Clin Dermatol; 2005; 6(1):49-59. PubMed ID: 15675890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of etanercept in the treatment of psoriasis and psoriatic arthritis.
    Fuchs BS; Hadi S
    Rev Recent Clin Trials; 2006 Sep; 1(3):259-63. PubMed ID: 18473978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-label dermatologic uses of anti-TNF-a therapies.
    Alexis AF; Strober BE
    J Cutan Med Surg; 2005 Dec; 9(6):296-302. PubMed ID: 16699906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha inhibitors in dermatology.
    Cordoro KM; Feldman SR
    Skin Therapy Lett; 2007 Sep; 12(7):4-6. PubMed ID: 17940711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spotlight on etanercept in plaque psoriasis and psoriatic arthritis.
    Goldsmith DR; Wagstaff AJ
    BioDrugs; 2005; 19(6):401-3. PubMed ID: 16392892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etanercept for severe psoriasis and psoriatic arthritis: observations on combination therapy.
    Iyer S; Yamauchi P; Lowe NJ
    Br J Dermatol; 2002 Jan; 146(1):118-21. PubMed ID: 11841377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept for psoriasis: two case reports.
    Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A
    Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etanercept, a TNF antagonist for treatment for psoriatic arthritis and psoriasis.
    Mease PJ
    Skin Therapy Lett; 2003 Jan; 8(1):1-4. PubMed ID: 12728284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
    Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
    Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.
    Mease PJ; Goffe BS; Metz J; VanderStoep A; Finck B; Burge DJ
    Lancet; 2000 Jul; 356(9227):385-90. PubMed ID: 10972371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Etanercept: efficacy and safety for approved indications.
    Kerensky TA; Gottlieb AB; Yaniv S; Au SC
    Expert Opin Drug Saf; 2012 Jan; 11(1):121-39. PubMed ID: 22074366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.
    Bonafede M; Joseph GJ; Princic N; Harrison DJ
    J Med Econ; 2013 Sep; 16(9):1120-8. PubMed ID: 23808901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept.
    Ducharme E; Weinberg JM
    Expert Opin Biol Ther; 2008 Apr; 8(4):491-502. PubMed ID: 18352852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis.
    Fleischmann R; Iqbal I
    Drugs Aging; 2007; 24(3):239-54. PubMed ID: 17362051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept for the treatment of psoriasis and psoriatic arthritis.
    Gottlieb AB
    Dermatol Ther; 2004; 17(5):401-8. PubMed ID: 15379775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of etanercept in chronic immune-mediated disease.
    Murdaca G; Spanò F; Contatore M; Guastalla A; Magnani O; Puppo F
    Expert Opin Drug Saf; 2014 May; 13(5):649-61. PubMed ID: 24654562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etanercept in psoriasis.
    Papp KA
    Expert Opin Pharmacother; 2004 Oct; 5(10):2139-46. PubMed ID: 15461549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis.
    Krueger G; Callis K
    Arch Dermatol; 2004 Feb; 140(2):218-25. PubMed ID: 14967799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.